People: Applied DNA Sciences Inc (APDN.OB)

APDN.OB on OTC BB

0.21USD
20 May 2013
Price Change (% chg)

$-0.02 (-6.81%)
Prev Close
$0.23
Open
$0.23
Day's High
$0.24
Day's Low
$0.20
Volume
4,239,242
Avg. Vol
3,649,391
52-wk High
$0.31
52-wk Low
$0.02

Search Stocks

Summary

Name Age Since Current Position

James Hayward

 59 2007 Chairman of the Board, President, Chief Executive Officer

Kurt Jensen

 55 2007 Chief Financial Officer

Ming-Hwa Liang

 49 2005 Secretary, Strategic Technology Development Officer

John Bitzer

 51 2011 Independent Director

Karol Gray

 59 2011 Independent Director

Charles Ryan

 48 2011 Independent Director

Yacov Shamash

 62 2006 Independent Director

Sanford Simon

 70 2006 Independent Director
» Insider Trading

Biographies

Name Description

James Hayward

 Dr. James A. Hayward, Ph.D., is Chairman of the Board, President, Chief Executive Officer of Applied DNA Sciences, Inc. Dr. James A. Hayward has been Chief Executive Officer since March 17, 2006 and President and the Chairman of the Board of Directors since June 12, 2007. He was previously acting Chief Executive Officer since October 5, 2005. Dr. Hayward received his Ph.D. in Molecular Biology from the State University of New York at Stony Brook in 1983 and an honorary Doctor of Science from the same institution in 2000. His experience with public companies began with the co-founding of one of England’s first biotechnology companies–Biocompatibles. Following this, Dr. Hayward was Head of Product Development for the Estee Lauder companies for five years. In 1990 he founded The Collaborative Group, a provider of products and services to the biotechnology, pharmaceutical and consumer-product industries based in Stony Brook, where he served as Chairman, President and Chief Executive Officer for 14 years. During this period, The Collaborative Group created several businesses, including The Collaborative BioAlliance, a contract developer and manufacturer of human gene products, that was sold to Dow Chemical in 2002, and Collaborative Labs, a service provider and manufacturer of ingredients for skincare and dermatology that was sold to Engelhard (now BASF) in 2004.

Kurt Jensen

 Mr. Kurt H. Jensen, M.Sc.(Cand. Merc.) is Chief Financial Officer of Applied DNA Sciences Inc. Prior to that date, for a period of more than 23 years, he was employed by Point of Woods Homes, Inc. Mr. Jensen was awarded a M.Sc. in Economics and Business Administration from the Copenhagen Business School in 1983.

Ming-Hwa Liang

 Mr. Ming-Hwa Liang, Ph.D., is Secretary, Strategic Technology Development Officer of Applied DNA Sciences Inc. Between May 1999 and September 2005, Mr. Liang had been the director of research and development at Biowell Technology Inc. Mr. Liang received a B.S. in Bio-Agriculture from Colorado State University in 1989, a M.S. in Horticulture from the University of Missouri at Columbia in 1991, his Ph.D. in Plant Science from the University of Missouri at Columbia in 1997 and his LL.M. in Intellectual Property Law from Shih Hsin University, Taiwan in 2004.

John Bitzer

 Mr. John Bitzer, III is Independent Director of Applied DNA Sciences, Inc. Mr. Bitzer is President and Chief Executive Officer of ABARTA, Inc., a private, third-generation holding-company with operations in the soft drink beverages, newspaper publishing, oil and gas exploration and development, and ethnic and frozen food industries (“ABARTA”). In 1985, Mr. Bitzer began his career in sales for the Cleveland Coca-Cola Bottling Company. He has been Publisher of Atlantic City Magazine in Atlantic City, N.J. In 1994 he founded the ABARTA Media Group and held the position of Group Publisher. In 1997 he was named President and Chief Operating Officer of ABARTA and has been President and Chief Executive Officer since 1999. He is also a director of the Institute for Entrepreneurial Excellence at the University of Pittsburgh. Mr. Bitzer has a degree from the University of Southern California and an MBA from the University of Michigan.

Karol Gray

 Ms. Karol Gray is Independent Director of Applied DNA Sciences, Inc. In December 2011, Ms. Gray assumed the position of Vice President for Finance and Administration at UNC-Chapel Hill. Ms. Gray previously was the Vice President for Finance and Administration and the Chief Financial Officer at the University at Stony Brook. While Ms. Gray was working at Stony Brook University, she actively served on several committees, including the Brookhaven National Laboratory Audit Committee, the Presidential Budget Working Group, and the Investment Subcommittee of the Research Foundation of the State University of New York, and was a member of the Executive Committee of the State University of New York Business and Officers Association. Ms. Gray holds a Bachelor in Business Administration from Hofstra University.

Charles Ryan

 Dr. Charles Ryan is Independent Director of Applied DNA Sciences, Inc. Dr. Charles Ryan joined the Board of Directors on August 2011. Dr. Ryan is the Sr. Vice President, and Chief Intellectual Property Counsel at Forest Laboratories, where he has been employed since 2003. Forest, with a market capitalization of nearly $10 billion, develops and markets pharmaceutical products in therapeutic categories including central nervous system, cardiovascular, anti-infective, respiratory, gastrointestinal, and pain management medicine. Dr. Ryan earned a doctorate in oral biology and pathology from Stony Brook University and a law degree from Western New England University.

Yacov Shamash

 Dr. Yacov A. Shamash, Ph.D., is Independent Director of Applied DNA Sciences Inc. Dr. Shamash is Vice President of Economic Development at the State University of New York at Stony Brook. Since 1992, he has been the Dean of Engineering and Applied Sciences and the Harriman School for Management and Policy at the University, and Founder of the New York State Center for Excellence in Wireless Technologies at the University. Dr. Shamash developed and directed the NSF Industry/University Cooperative Research Center for the Design of Analog/Digital Integrated Circuits from 1989 to 1992 and also served as Chairman of the Electrical and Computer Engineering Department at Washington State University from 1985 until 1992. Dr. Shamash also serves on the Board of Directors of Keytronic Corp., Netsmart Technologies, Inc., American Medical Alert Corp., and Softheon Corp.

Sanford Simon

 Dr. Sanford R. Simon, Ph.D., is Independent Director of Applied DNA Sciences Inc. Dr. Simon has been a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook since 1997. He joined the faculty at Stony Brook as an Assistant Professor in 1969 and was promoted to Associate Professor with tenure in 1975. Dr. Simon was a member of the Board of Directors of The Collaborative Group from 1995 to 2004. From 1967 to 1969 Dr. Simon was a Guest Investigator at Rockefeller University. Dr. Simon received a B.A. in Zoology and Chemistry from Columbia University in 1963, a Ph.D. in Biochemistry from Rockefeller University in 1967, and studied as a postdoctoral fellow with Nobel Prize winner Max Perutz in Cambridge, England. He maintains an active research laboratory studying aspects of cell invasion in cancer and inflammation and novel strategies of drug delivery; he also teaches undergraduate, graduate, medical, and dental students.

Basic Compensation

Name Fiscal Year Total

James Hayward

 242,334

Kurt Jensen

 292,308

Ming-Hwa Liang

 139,616

John Bitzer

 --

Karol Gray

 --

Charles Ryan

 --

Yacov Shamash

 --

Sanford Simon

 --
As Of 29 Sep 2012

Options Compensation

Name Options Value

James Hayward

 0 0

Kurt Jensen

 0 0

Ming-Hwa Liang

 0 0

John Bitzer

 0 0

Karol Gray

 0 0

Charles Ryan

 0 0

Yacov Shamash

 0 0

Sanford Simon

 0 0

Insider Trading

» Full list on Insider Trading
Search Stocks